EHRA Premium Access

Optimizing catheter ablation of atrial fibrillation by a novel wide-band dielectric imaging system: first experience on real-time wall thickness measurement

Congress Session

About the speaker

Doctor Laura Rottner

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
0 follower

5 more presentations in this session

Acute safety and efficacy outcome of pulmonary vein isolation using pulsed field ablation technology

Speaker: Doctor K. Nentwich (Bad Neustadt a. d. Saale, DE)

Thumbnail

Periaortic scar-related ventricular tachycardia in patients with aortic valve replacement: transcatheter ablation is feasible and decisive.

Speaker: Doctor L. Cardelli (Bologna, IT)

Thumbnail

Zero-fluoroscopy catheter ablation in pregnant women: outcomes and prognosis

Speaker: Doctor A. Smagulova (Nursultan, KZ)

Thumbnail

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

Speaker: Doctor C. Martin (Cambridge, GB)

Thumbnail

Influence of atrial cycle length and site of origin on the peak frequency of bipolar electrograms to discriminate isthmus conduction in atrial scar

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Access the full session

Moderated ePosters - Tips and trics to optimize ablation

Speakers: Doctor L. Rottner, Doctor K. Nentwich, Doctor L. Cardelli, Doctor A. Smagulova, Doctor C. Martin...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

This platform is supported by

logo Novo Nordisk